证券代码：688203 证券简称：海正生材 公告编号：2026-08 浙江海正生物材料股份有限公司 关于诉讼事项的进展公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 具体内容详见公司于2025年12月20日在上海证券交易所网站 （www.sse.com.cn）及相关指定信息披露媒体上披露的《浙江海正生物材料股份 1 案件所处的诉讼阶段：一审判决 上市公司所处的当事人地位：原告 涉案的金额：赔偿附带民事诉讼原告人共计人民币 500 万元（含合理 维权费用） 是否会对上市公司损益产生负面影响：鉴于本次判决为一审判决，原 被告均可在法定期限内向上级人民法院提起上诉，该判决是否为终审 判决存在不确定性，该案件对公司本期利润或期后利润的具体影响暂 无法评估，公司将根据《企业会计准则》进行相应会计处理。敬请投 资者注意投资风险。 重要内容提示： 一、本次诉讼起诉的基本情况 由于郑某某、柯某某、钱某某、普立思生物科技有限公司、安徽金普瑞新材 料有限公司、张家港市沃尔特精密机械有限公司涉嫌侵犯浙江海正生物材料股份 有限公司（以下简称 ...

Group 1: Gas Turbine Sector - The gas turbine sector is emphasized due to deep penetration into overseas supply chains and the dual logic of domestic aviation reform, which is expected to resonate positively[3] - The North American AIDC demand expansion, coupled with aging power grids, is leading to a structural power supply gap that is continuously increasing[6] - The global gas turbine market is highly concentrated, with GE Vernova, Siemens Energy, and Mitsubishi Heavy Industries collectively holding about 85% market share[32] Group 2: Commercial Aerospace - The commercial aerospace sector is expected to see a new round of catalysts with the successful testing of reusable rocket technology, enhancing the prospects for commercial space ventures[38] - China's G60 satellite constellation plans to launch 1,296 satellites by the end of 2027 and 15,000 by 2030, indicating a significant demand for satellite launches[51] - The application end of the aerospace sector is focusing on core components such as communication terminal basebands, RF chips, and phased array antennas, which are expected to see stable or increasing value under cost reduction trends[55] Group 3: 3D Printing - The industrial-grade 3D printing sector is poised for a breakthrough due to material cost reductions and equipment efficiency improvements, marking a significant turning point for mass adoption[58] - The consumer-grade 3D printing market is accelerating towards a creative era, driven by AI empowerment, ecosystem strengthening, and supply chain cost reductions[68] - In 2025, the export value of 3D printers from China is projected to reach 11.355 billion yuan, reflecting a year-on-year growth of 39.1%[73] Group 4: Tungsten Market - The price of tungsten has surged significantly, with 65% black tungsten concentrate reaching 800,000 yuan per ton, up 73.91% since the beginning of 2026[80] - The increase in tungsten prices is driven by tightened supply and strategic pricing, with China's export controls on tungsten and other strategic metals contributing to this trend[79] - Companies with mining assets or expectations of asset injections, such as Zhongtung High-tech and Xiamen Tungsten, are expected to benefit directly from rising tungsten prices[81]

Group 1 - The company, Haizheng Shengcai (688203.SH), has completed its share repurchase program as of February 27, 2026, with a total of 2.2038 million shares repurchased, accounting for 1.09% of the total share capital [1] - The highest repurchase price was 15.98 CNY per share, while the lowest was 7.76 CNY per share, with an average repurchase price of 11.10 CNY per share [1] - The total amount spent on the share repurchase was 24.4515 million CNY, excluding transaction fees such as stamp duty and commissions [1]

Group 1 - The core point of the article is that Haizheng Shengcai announced a share buyback plan, having repurchased a total of 2,203,788 shares, which represents 1.09% of its total share capital [1] - The total funds used for the buyback amounted to 24,451,466.50 yuan, with an average repurchase price of 11.10 yuan per share [1] - The shares repurchased will be used entirely for the employee stock ownership plan or equity incentives [1]

Core Insights - The company, Haizheng Shengcai, reported its 2025 annual performance, indicating a total operating revenue of 851.5873 million yuan, which represents a year-on-year growth of 0.76% [2] - The net profit attributable to the parent company's shareholders was 9.2133 million yuan, showing a significant decline of 74.05% compared to the previous year [2] Financial Performance - Total operating revenue for 2025 reached 851.5873 million yuan, reflecting a slight increase of 0.76% year-on-year [2] - The net profit attributable to the parent company was recorded at 9.2133 million yuan, marking a substantial decrease of 74.05% from the prior year [2]

Core Viewpoint - The company reported a slight increase in total revenue for 2025, but significant declines in profits, indicating challenges in maintaining profitability amidst competitive pressures and rising costs [1] Financial Performance - The company achieved total operating revenue of 851.59 million, a year-on-year increase of 0.76% [1] - Operating profit was 17.17 million, down 64.48% year-on-year [1] - Total profit amounted to 16.80 million, reflecting a decrease of 64.39% compared to the previous year [1] - Net profit attributable to the parent company was 9.21 million, showing a decline of 74.05% year-on-year [1] - Net profit attributable to the parent company after deducting non-recurring gains and losses was 7.10 million, down 77.25% year-on-year [1] Operational Insights - The company’s production and operational activities progressed steadily, with an upward trend in the production and sales volume of its main products [1] - The company focused on deepening and expanding its domestic market, resulting in increased sales [1] Market Challenges - The company faced downward pressure on product sales prices due to market competition, which compressed gross profit margins [1] - A decrease in interest income and foreign exchange gains led to an increase in financial expenses [1] - The transition of construction projects to fixed assets resulted in increased depreciation and tax expenses, further squeezing profits for the period [1]

Group 1 - The company focuses on the research, production, and sales of polylactic acid (PLA) resin, which is a key material for 3D printing filaments [2] - The company has established strong upstream and downstream partnerships with major 3D printing filament manufacturers [2]

证券代码：688203 证券简称：海正生材 公告编号：2026-07 浙江海正生物材料股份有限公司 关于股份回购实施结果暨股份变动的公告 2025 年 3 月 11 日，公司召开第七届董事会第十三次会议审议通过了《关于 调整回购股份资金来源的议案》，公司将回购资金来源由"自有资金"调整为"自 有资金和股票回购专项贷款"。具体内容详见公司于 2025 年 3 月 12 日在上海证 券交易所网站（www.sse.com.cn）披露的《浙江海正生物材料股份有限公司关于调 整回购资金来源暨收到股票回购专项贷款承诺函的公告》（公告编号：2025-07）。 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： | 回购方案首次披露日 | 2024/8/29 | | | | | | --- | --- | --- | --- | --- | --- | | 回购方案实施期限 | 2024 年 8 月 2 月 | 28 | 日~2026 | 年 | 27 日 | | 预计回购金额 | 2,000万元~3,000万元 | | | | ...

Financial Performance - In 2025, the company achieved total operating revenue of 851.59 million yuan, a year-on-year increase of 0.76%[2] - Operating profit decreased by 64.48% to 17.17 million yuan, while total profit fell by 64.39% to 16.80 million yuan[4] - Net profit attributable to shareholders of the parent company was 9.21 million yuan, down 74.05% compared to the previous year[4] - The net profit after deducting non-recurring gains and losses was 7.10 million yuan, a decline of 77.25% year-on-year[4] - Basic earnings per share decreased by 72.22% to 0.05 yuan[6] Assets and Equity - Total assets at the end of the reporting period were 2,014.25 million yuan, a decrease of 2.49% from the beginning of the period[4] - Shareholders' equity attributable to the parent company was 1,476.44 million yuan, down 1.01% from the beginning of the period[4] Market and Financial Conditions - The decline in profits was primarily due to market competition leading to downward pressure on product sales prices, resulting in reduced gross margins[5] - Financial expenses increased due to a decrease in interest income and exchange gains, alongside rising depreciation and taxes from ongoing investment projects[5] - The financial data presented is preliminary and unaudited, with potential discrepancies in the final annual report[7]

Core Viewpoint - The company reported a slight increase in total revenue for 2025, but significant declines in profits and net income compared to the previous year [1] Financial Performance - The company achieved total operating revenue of 851.59 million yuan in 2025, representing a year-on-year growth of 0.76% [1] - Operating profit was reported at 17.17 million yuan, a decrease of 64.48% year-on-year [1] - Total profit amounted to 16.80 million yuan, down 64.39% compared to the previous year [1] - The net profit attributable to the parent company's shareholders was 9.21 million yuan, reflecting a decline of 74.05% year-on-year [1] - The net profit attributable to the parent company after deducting non-recurring gains and losses was 7.10 million yuan, which is a decrease of 77.25% year-on-year [1]